Jump to:

Anne Landman's Collection

Note to Mr. Crawford

Date: 18 Dec 1986
Length: 3 pages
101432831-101432833 Exhibit 10
Jump To Images
youth 3003

Abstract

This is a secret and confidential letter written to a scientist who suggested that the British American Tobacco Company (BAT) should try and make a safer cigarette. This is the definitive document outlining the industry's reasons for not making a safer cigarette. Chief among the reasons is that by doing so, the industry's traditional products would then be considered unsafe:

...in attempting to develop a "safe" cigarettes you are, by implication in danger of being interpreted as accepting that the current product is "unsafe" and this is not a position that I think we should take.

The other reasons are that no matter what they do, they will never be able to appease their critics, and that making a safer cigarette would be too expensive.

Fields

Notes

This document was first posted to Doc-Alert in 1999.

Quotes

You will remember that when we last met in Montreal we spoke about the approach you believe should be taken in fundamental research to produce improved cigarettes.

I have reviewed the position with my colleagues. Sincere there is such a wide discrepancy between your approach and that of the rest of the Group, I thought that I should write to explain why it is that I cannot support your contention that we should give a higher priority to projects aimed at developing a "safe" cigarette (as perceived by those who claim our current product is "unsafe") by either eliminating, or at least reducing to acceptable levels, all components claimed by our critics to be carcinogenic.

The BAT objective is and should be to make the whole subject of smoking acceptable to the authorities and to the public at large since that is the real challenge facing the industry. Not only do I believe that this is the right objective but I also believe that it is an achievable one....

.....Furthermore, I believe there are other important objections inherent in your approach.

Firstly, your objective is probably inattainable - no matter what can be done in chemical terms (and I believe this to be very limited) there will continue to be strong vocal factions that seek to denigrate the product and they are likely to continue to move the goal posts away from whatever initial target we were able to achieve. A second practical objection is that in attempting to develop a "safe" cigarettes you are, by implication in danger of being interpreted as accepting that the current product is "unsafe" and this is not a position that I think we should take.

As you can see, there is no disagreement on the importance that we all place on the need for fundamental research leading to results which will have a practical impact on the acceptability of our product.

Where we part company...is that we do not believe that there is a sufficiently high chance of a successful outcome to justify committing the very large scale of resources that would be necessary to pursue the direct but arguably over-simplistic approach which your people are proposing. That is why I cannot support this line of research. [The underlining appears in the original.]

Company
British American Tobacco Industry (BAT)
Author
Sheehy, P
Recipient
Crawford
Region
Canada
Litigation
Minnesota Trial Exhibit 10,821
Type
Letter
Subject
Liability
Product design
safer cigarette
Tobacco Industry

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: 3003
£ONFIBENTIJ~L
Page 2: 3003
CONFII3ENTI ,L ' hLshc: priority to pro~cet| slued at deveLopLn| I 'safe' The h~T objectors ~m ted should be to us~o t~e vho~o subject only do I believe thet ~hLc Lc the rLSht objective buC Z else believe ~he~ ~ ~e in sch~ev&hle The Group alreedy ben sever81 approecheJ Ln place Co recpoad co ~hlc objective. These ~¢cludl ezpar~uentsL science, carried york. eccepcabll/t~ of sickenS. Understandably, the ct~ssttou ~ssue Lc of eL1 releveuc publ/cetiona cheC can chrov l~|hc on ChLs issue. go sponsor reslarch york on mechanics of diocese, lncZndLn$ poycholo|~cel or Generic predicpoeicioo, as yeLL se probes| the liaple conclusions of vhnt Ls probchl~ rather poor tp~deeloLoiy. product uodLfLcetion, vhlch the7 believe could hs deslrchLe, vc v£11 respond. The Group has several re.earth pro~eccs, us~nly ~n utCrosauluec end free redLcaLc buc extends co the abLILC7 ~o o~ '1or risk ap£dcololoJ~'. There ere reputable external czptrcc vho believe chic ~h~o Lo a h~thly iapraeloo science sod ve ere f/ediu| caius for thee to ezpreJc choir concerns. In perelLel, vo locke coder csrefulLy controlled eondicLool| ocher of our research Cease ere oeakLa$ products that reduce the burden o~ overall caokc or its ~arcLcular cospooeuts Lo the eovLronuoat. BAT Co LrD - Mt×xLsoT?, Tos. :co LIXlG.~.TIOX
Page 3: 3003
CONFIDENTIAL o 2 - euokl~|'. Ve are supporc~u| research on che phsresccLo|~¢41 e~ec~s of aLcotZas (the key eleoseC of our produ¢: vhtch, dLleeoe, huc v~ch the v~doep~eed dLeorders of senile deueu~te or The |&Tvlev Lo thug g~de~ ~hen ~het eoooupaeeed La the Zuosco approach. F~cheruore, ~ hollers there ore other ~uportant ob~ecctouJ ~uheroot 1~ your approach. FLrsc17, your ob~ectLve Le probab~7 ooac~eLoab2o - co ua~car to decistere ~he produce Bud they art l£~o~y to continue to save achLeve. th£l ~l not • poJ~c~oo th•~ Z chtu~ ve should ~ahe. rtJu~$ vh/ch vL~ have e p=ac~ceL ~spa¢~ co the acceptability O~ our product. not beLLevo ~h•c ~here ~e 8 eu~cLeucLy hLsh cheats of a successful outcome co Justify commfct~o| the very l•r|e scale of • rjusb17 ovor-a~up~t~c approach ~hich your people ere propo|iu|. ThLe £s vh7 Z cannot support ch~s Lies of research. approach co chLs £uportaot quest/ca Is ¢Zosod and Z hope chec

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: